Inhibition of Dermatitis Development by Sopungsan in Nc/Nga Mice |
Pokhare, Yuba Raj
(College of Pharmacy, Chosun University)
Lim, Sung-Chul (Department of Pathology, College of Medicine, Chosun University) Kim, Sang-Chan (Department of Prescription, College of Oriental Medicine, Daegu Haany University) Choi, Hoo-Kyun (College of Pharmacy, Chosun University) Kang, Keon-Wook (College of Pharmacy, Chosun University) |
1 | Lee, J.Y., Woo, E.R. and Kang, K.W. (2005). Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. J. Ethnopharmacol., 97, 561-566 DOI ScienceOn |
2 | Matsuda, H., Watanabe, N., Geba, G.P., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ushio, H., Saito, S., Askenase, P.W. and Ra, C. (1997). Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol., 9, 461-466 DOI ScienceOn |
3 | Nakayama, T., Hieshima, K., Nagakubo, D., Sato, E., Nakayama, M., Kawa, K. and Yoshie, O. (2004). Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J. Virol., 78, 1665-1674 DOI |
4 | Kotani, M., Matsumoto, M., Fujita, A., Higa, S., Wang, W., Suemura, M., Kishimoto, T. and Tanaka, T. (2000). Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J. Allerg. Clin. Immunol., 106, 159-166 DOI ScienceOn |
5 | Hanifin, J. and Rajka, G. (1980). Diagnostic features of atopic dermatitis. Acta. Dermato-Venereologica, 92, 44-47 |
6 | Park, S.J., Lee, S.G., Baek, J.H., Byun, S.H. and Kim, S.C. (2006). Effect of sopung-san on contact hypersensitivity induced by repeat elicitation of DNCB. Kor. J. Orient. Physiol. Pathol., 20, 623-628 과학기술학회마을 |
7 | Furukawa, H., Takahashi, M., Nakamura, K. and Kaneko, F. (2004). Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis. J. Dermat. Sci., 36, 165-172 DOI ScienceOn |
8 | Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S. and Yoshie, O. (1997). The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem., 272, 15036-15042 DOI ScienceOn |
9 | Vestergaard, C., Bang, K., Gesser, B., Yoneyama, H., Matsushima, K. and Larsen, C.G. (2000). A Th2 Chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol., 115, 640-646 DOI ScienceOn |
10 | Soter, N.A. (1989). Morphology of atopic eczema. Allergy, 44, 16-19 DOI ScienceOn |
11 | Sandoval-Lopez, G. and Teran, L.M. (2001). TARC: novel mediator of allergic inflammation. Clin. Exp. Allerg., 31, 1809-1812 DOI ScienceOn |
12 | Berin, M.C., Eckmann, L., Broide, D.H. and Kagnoff, M.F. (2001). Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am. J. Resp. Cell. Mol. Biol., 24, 382-389 DOI ScienceOn |
13 | Kawasaki, S., Takizawa, H., Yoneyama, H., Nakayama, T., Fujisawa, R., Izumizaki, M., Imai, T., Yoshie, O., Homma, I., Yamamoto, K. and Matsushima, K. (2001). Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J. Immunol., 166, 2055-2062 DOI |
14 | Leung, D.Y. (1997). Atopic dermatitis: immunobiology and treatment with immune modulators. Clin. Exp. Immunol., 107, 25-30 |
15 | Komine, M., Kakinuma, T., Kagami, S., Hanakawa, Y., Hashimoto, K. and Tamaki, K. (2005). Mechanism of thymusand activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Invest. Dermatol., 125, 491-498 DOI ScienceOn |